At a glance
ClinicalIndex Comparison RecordN/ACompleted· 900 enrolled
Drug / intervention
Blood drawprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacogenomics of Contraception: Genetic Variants and Etonogestrel Pharmacokinetics
In Brief
An observational study evaluating Blood draw for Contraception. Completed, enrolled 900 participants across 1 site.
Detailed Summary
The proposed study will investigate the relationship between genetic variants and serum contraceptive hormone levels, specifically the progestin etonogestrel. This study will provide the foundation for future pharmacogenomic investigations of more commonly used contraceptive methods with higher failure rates.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesUnited States
CollaboratorsSociety of Family Planning
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartMar 2017
First PostedMar 2017
Primary CompletionApr 2022
TodayJul 2026
First PostedMar 27, 2017
Enrollment StartMar 23, 2017
Primary CompletionApr 29, 2022
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 9.3 years ago
Interventions
Blood drawprocedure
The Investigators will collect serum and whole blood from participants.